ArticleBMC microbiology2026
Fatty acids from Hermetia illucens larvae disrupt membrane integrity in colistin-resistant Acinetobacter baumannii.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe overuse and prolonged application of antibiotics have led to the emergence of multidrug-resistant bacterial pathogens, notably Acinetobacter baumannii, a leading cause of nosocomial infections and increased mortality in healthcare settings. In natural conditions, fatty acids possess well-documented antibacterial activity. This research investigates an eco-friendly way to extract fat from Hermetia illucens (HI) larvae to analyze its antimicrobial properties against colistin-resistant A. baumannii ATCC 19606.
methodsLarval fat from H. illucens was processed using a sustainable extraction protocol to yield multiple fractions. Antibacterial activity was assessed via disc diffusion and broth microdilution assays. The most potent fraction, acidic water methanol extract 3 (AWME3), was further evaluated for inhibition zone diameter, minimum inhibitory concentration (MIC), MIC50, and minimum bactericidal concentration (MBC). Salt tolerance assays were conducted under 0-10% NaCl conditions to assess robustness. Morphological and intracellular changes were examined using electron microscopy.
resultsAmong the obtained fractions, the third acidic water methanol extract (AWME3) demonstrated the highest activity against A. baumannii ATCC 19606. AWME3 exhibited a clear inhibition zone of 18.1 ± 0.35 mm at 20 mg/mL. The minimum inhibitory concentration (MIC), MIC50, and minimum bactericidal concentration (MBC) were found to be 380 µg/mL, 222 µg/mL, and 380 µg/mL, respectively. Complete inhibition of colony formation was observed at both MIC and 2×MIC levels under NaCl concentrations ranging from 0 to 10%. Electron microscopy revealed that fatty acids severely damaged bacterial cell walls and membranes, increasing permeability and causing leakage of cell contents, leading to cell death.
conclusionsFatty acid-enriched extracts from H. illucens larvae, particularly AWME3, exhibited potent antibacterial activity against colistin-resistant A. baumannii, likely through membrane-disruptive mechanisms. These findings highlight the potential of insect-derived bioactive compounds as sustainable alternatives for managing MDR pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.